Core Insights - Calian Group Ltd. has been recognized by TIME Magazine as one of Canada's Best Companies and by Forbes as one of Canada's Best Employers for Company Culture, highlighting its commitment to excellence and a positive workplace environment [1][2][3] Company Performance - The recognitions reflect Calian's strong performance metrics over the past three years, including employee satisfaction, revenue growth, and sustainability transparency [3] - The company has a global team of 5,000 employees who contribute to its success and community impact [3][4] Company Culture - Calian emphasizes the importance of its employees, stating that they are the backbone of the company and crucial for its high performance and innovation [4] - The company focuses on diversity, equity, inclusion, and belonging to enhance its workplace culture and better serve its communities [4] Industry Position - Calian is positioned as a leader in delivering mission-critical solutions across the defence, space, and healthcare sectors, showcasing its momentum in these strategic industries [2][3] - The company aims to combine purpose with progress as it continues to grow and innovate [3] Company Overview - With over 40 years of experience, Calian provides mission-critical solutions that empower organizations in critical industries to manage risks and drive progress [6] - The company is headquartered in Ottawa, Canada, and is trusted worldwide for its tailored solutions that address complex challenges [6]

Astrana Health, Inc. (ASTH) closed the last trading session at $25.12, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $49.56 indicates a 97.3% upside potential.The average comprises nine short-term price targets ranging from a low of $36.00 to a high of $70.00, with a standard deviation of $12.39. While the lowest estimate indicates an increase of 43.3% from the curre ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are ...

Core Viewpoint - Centene Corporation is facing a class action lawsuit due to allegations of misleading investors about its financial health and growth prospects, leading to a significant drop in stock price [1][3][5]. Group 1: Lawsuit Details - The lawsuit, titled Lunstrum v. Centene Corporation, seeks to represent investors who acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange Act of 1934 [1][2]. - The allegations center around claims that Centene and its executives provided an overly optimistic view of the company's financial situation, particularly regarding revenue outlook and enrollment rates [3][4]. Group 2: Financial Impact - On July 1, 2025, Centene withdrew its 2025 guidance, stating that market growth across 22 states, which accounts for 72% of its marketplace membership, was "lower than expected," leading to a revised guidance of approximately $1.8 billion or an adjusted diluted EPS of $2.75 [4]. - Following this announcement, Centene's stock price fell by more than 40%, resulting in billions of dollars in lost shareholder value [5]. Group 3: Investigative Actions - Hagens Berman, a national shareholders rights firm, is investigating the claims and encourages affected investors to report their losses [2][6]. - The firm suggests that if the allegations are proven true, they indicate a disconnect between Centene's public statements and its actual performance metrics [6].

About Prestige Consumer Healthcare Inc. Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio of brands include Monistat and Summer's Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears® eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enema ...

Core Insights - HealthLynked Corp. has engaged Meridian Group to identify and secure strategic partnerships aimed at accelerating the adoption of its healthcare platform, increasing revenue, and positioning the company for long-term growth, including a potential uplisting to the Nasdaq Capital Market [1][4]. Company Strategy - The company is focused on scaling its healthcare ecosystem, which includes telemedicine, patient record management, and AI-driven care recommendations, by forming strategic alliances with healthcare insurers, third-party administrators, and technology providers [2][4]. - Meridian Group will assist in establishing banking relationships to support HealthLynked's efforts in transforming care management across the healthcare landscape [3]. Leadership and Advisory - David Chua from Meridian Group will lead the advisory effort and has joined HealthLynked as a strategic advisor [3]. - The engagement with Meridian Group is seen as a critical step in increasing market visibility, attracting institutional investors, and evaluating synergistic acquisition opportunities [4]. Market Opportunities - HealthLynked aims to unlock new revenue streams and enhance shareholder value by identifying partners that can drive rapid adoption of its platform through enterprise deployment and vertical integration [4]. - The company sees significant opportunities to deliver value across multiple healthcare sectors, including pharmaceuticals and medical research, leveraging its technology to improve clinical outcomes [4].

This AI Founder Became A Billionaire By Building ChatGPT For Doctors https://t.co/IGtxJpgJoU ...

Toronto, Ontario--(Newsfile Corp. - July 15, 2025) - Northwest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (the "REIT" or "Northwest"), a leading owner and operator of healthcare real estate infrastructure in North America, Brazil, Europe and Australasia, announced today that the Trustees of the REIT have declared a distribution of $0.03 per unit for the month of July 2025, representing $0.36 per unit on an annualized basis. The distribution will be payable on August 15, 2025, to unith ...

This AI Founder Became A Billionaire By Building ChatGPT For Doctorshttps://t.co/5dmb0SmJPo https://t.co/S9xRYZBvCK ...

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the launch of Wellbound, a bold new employee assistance program (EAP) designed to empower a more engaged, healthier workforce. The new program, purpose-built for the company’s employer and health plan clients in the U.S., leverages Teladoc Health’s unmatched scale, clinical product portfolio and consumer engagement expertise to help organizations create a powerful “on-ramp” for long-te ...